Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients

Journal of Neural Transmission

Volumn 116, Issue 4, 2009, Pages 443-450

  Funke, Claudia ^a   Soehn, Anne S ^a   Tomiuk, Juergen ^a   Riess, Olaf ^a   Berg, Daniela ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Blood brain barrier; Case control study; P glycoprotein; Parkinson's disease; Single nucleotide polymorphism; SNaPshot

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN P; IRON; MULTIDRUG RESISTANCE PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CELL INCLUSION; CODING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANTIA NIGRA;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EUROPE; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 67349154520     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0196-y     Document Type: Article

References (25)

1. LJ Bain GA LeBlanc 1996 Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein Toxicol Appl Pharmacol 141 288 298 (Pubitemid 26414376)
2. AL Bartels BN van Berckel M Lubberink 2008 Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease Parkinsonism Relat Disord 14 505 508
3. AL Bartels AT Willemsen R Kortekaas 2008 Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA J Neural Transm 115 1001 1009
4. D Berg 2006 Transcranial sonography in the early and differential diagnosis of Parkinson's disease J Neural Transm Suppl 70 249 254 (Pubitemid 44622207)
5. D Berg G Becker B Zeiler 1999 Vulnerability of the nigrostriatal system as detected by transcranial ultrasound Neurology 53 1026 1031 (Pubitemid 29442119)
6. D Berg M Gerlach MB Youdim 2001 Brain iron pathways and their relevance to Parkinson's disease J Neurochem 79 225 236 (Pubitemid 32988938)
7. D Berg B Jabs U Merschdorf 2001 Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy Biol Psychiatry 50 463 467 (Pubitemid 32885597)
8. D Berg W Roggendorf U Schroder 2002 Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury Arch Neurol 59 999 1005 (Pubitemid 34640761)
9. D Berg H Hochstrasser KJ Schweitzer 2006 Disturbance of iron metabolism in Parkinson's disease-ultrasonography as a biomarker Neurotox Res 9 1 13
10. C Borie F Gasparini P Verpillat 2002 Association study between iron-related genes polymorphisms and Parkinson's disease J Neurol 249 801 804 (Pubitemid 34754212)
11. M Drozdzik M Bialecka K Mysliwiec 2003 Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease Pharmacogenetics 13 259 263 (Pubitemid 36583992)
12. L Excoffier G Laval S Schneider 2005 Arlequin (version 3.0): an integrated software package for population genetics data analysis Evol Bioinforma 1 47 50
13. T Furuno MT Landi M Ceroni 2002 Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease Pharmacogenetics 12 529 534 (Pubitemid 35177082)
14. Jaccard J, Wan CK (1996) LISREL approaches to interaction effects in multiple regressions. Sage Publications, Thousand Oaks
15. R Kortekaas KL Leenders JC van Oostrom 2005 Blood-brain barrier dysfunction in parkinsonian midbrain in vivo Ann Neurol 57 176 179 (Pubitemid 40179854)
16. S Kubo N Hattori Y Mizuno 2006 Recessive Parkinson's disease Mov Disord 21 885 893 (Pubitemid 44184585)
17. CG Lee K Tang YB Cheung 2004 MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese J Med Genet 41 e60
18. I Litvan G Halliday M Hallett 2007 The etiopathogenesis of Parkinson disease and suggestions for future research. Part I J Neuropathol Exp Neurol 66 251 257 (Pubitemid 46559017)
19. T Moos T Rosengren Nielsen T Skjorringe 2007 Iron trafficking inside the brain J Neurochem 103 1730 1740 (Pubitemid 350126643)
20. S Ohtsuki T Terasaki 2007 Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development Pharm Res 24 1745 1758 (Pubitemid 47206624)
21. M Raymond F Rousset 1995 GENEPOP (Version 1.2): population genetics software for exact tests and ecumenicism J Hered 86 248 249
22. TA Rouault S Cooperman 2006 Brain iron metabolism Semin Pediatr Neurol 13 142 148
23. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: methods in molecular biology. Humana Press, Totowa
24. EK Tan LM Skipper 2007 Pathogenic mutations in Parkinson disease Hum Mutat 28 641 653 (Pubitemid 47047290)
25. EK Tan DK Chan PW Ng 2005 Effect of MDR1 haplotype on risk of Parkinson disease Arch Neurol 62 460 464 (Pubitemid 40349484)